Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,565 | -4,140 | -2,730 | -1,805 | -540 |
| Depreciation Amortization | 33 | 16 | 5 | 1 | 0 |
| Accounts payable and accrued liabilities | 113 | -228 | 380 | 37 | 14 |
| Other Working Capital | 1,554 | -858 | 325 | 176 | 14 |
| Other Operating Activity | 605 | 785 | 841 | 1,136 | 280 |
| Operating Cash Flow | $-8,260 | $-4,425 | $-1,179 | $-455 | $-231 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -66 | -21 | -4 | -2 |
| Investing Cash Flow | $-1 | $-66 | $-21 | $-4 | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,088 | N/A | 17,638 | 1,047 | N/A |
| Other Financing Activity | -3 | 0 | 3,225 | 0 | 0 |
| Financing Cash Flow | $4,085 | $N/A | $20,863 | $1,047 | $N/A |
| Beginning Cash Position | 15,944 | 20,435 | 771 | 184 | 416 |
| End Cash Position | 11,767 | 15,944 | 20,435 | 771 | 184 |
| Net Cash Flow | $-4,177 | $-4,491 | $19,664 | $587 | $-232 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,260 | -4,425 | -1,179 | -455 | -231 |
| Capital Expenditure | -1 | -66 | -21 | -4 | -2 |
| Free Cash Flow | -8,262 | -4,491 | -1,200 | -459 | -232 |